[go: up one dir, main page]

DE602007004110D1 - Hausstaubmilbenallergen - Google Patents

Hausstaubmilbenallergen

Info

Publication number
DE602007004110D1
DE602007004110D1 DE200760004110 DE602007004110T DE602007004110D1 DE 602007004110 D1 DE602007004110 D1 DE 602007004110D1 DE 200760004110 DE200760004110 DE 200760004110 DE 602007004110 T DE602007004110 T DE 602007004110T DE 602007004110 D1 DE602007004110 D1 DE 602007004110D1
Authority
DE
Germany
Prior art keywords
seq
dust mites
polypeptide
allergen
lacking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200760004110
Other languages
English (en)
Inventor
Rudolf Valenta
Margit Weghofer
Susanne Vrtala
Friedrich Horak
Peter Valent
Stefan Florian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomay AG
Original Assignee
Biomay AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38421740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602007004110(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay AG filed Critical Biomay AG
Publication of DE602007004110D1 publication Critical patent/DE602007004110D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43552—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects
    • G01N2333/43582—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects from mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Insects & Arthropods (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
DE200760004110 2006-04-28 2007-04-27 Hausstaubmilbenallergen Active DE602007004110D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0073306A AT503530A1 (de) 2006-04-28 2006-04-28 Polypeptid mit allergenen eigenschaften
PCT/AT2007/000201 WO2007124524A1 (en) 2006-04-28 2007-04-27 House dust mite allergen

Publications (1)

Publication Number Publication Date
DE602007004110D1 true DE602007004110D1 (de) 2010-02-11

Family

ID=38421740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200760004110 Active DE602007004110D1 (de) 2006-04-28 2007-04-27 Hausstaubmilbenallergen

Country Status (11)

Country Link
US (3) US20090104208A1 (de)
EP (1) EP2027149B2 (de)
JP (1) JP2009535020A (de)
CN (1) CN101432299B (de)
AT (2) AT503530A1 (de)
AU (1) AU2007246150B2 (de)
CA (1) CA2646158C (de)
DE (1) DE602007004110D1 (de)
ES (1) ES2339173T5 (de)
RU (1) RU2570563C2 (de)
WO (1) WO2007124524A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2110383A1 (de) 2008-04-14 2009-10-21 Biomay AG Hypoallergene Varianten
CO6260019A1 (es) * 2009-01-30 2011-03-22 Fundacion Universidad Del Norte Metodo y composicion inmunoquimica para la deteccion de alergenos de acaros usando anticuerpos policlonales igy
RU2630652C2 (ru) 2011-06-09 2017-09-11 Биомей Аг Гибридные белки-носители пептидов в качестве вакцин от аллергии
EP2543725A1 (de) 2011-07-08 2013-01-09 Biomay Ag Polysaccharidlyasen
EP3269730A1 (de) 2016-07-12 2018-01-17 Universität Salzburg Allergenvarianten
BR112020023041A2 (pt) 2018-05-11 2021-02-09 Astellas Pharma Inc. ácido nucleico para tratar alergia a ácaros
CN108892715B (zh) * 2018-06-12 2021-11-12 刘志刚 屋尘螨变应原Der p 33及其制备方法和应用
CN108892716B (zh) * 2018-06-12 2021-11-12 刘志刚 屋尘螨变应原Der p 29及其制备方法和应用
CN108840917B (zh) * 2018-06-12 2021-11-12 刘志刚 屋尘螨变应原Der p 30及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100379161B1 (ko) * 1994-04-14 2003-06-11 이뮤로직 파마시티컬 코포레이션 집먼지진드기에의한알레르기를치료하기위한의학적펩티드조성물
SE9903950D0 (sv) 1999-10-29 1999-10-29 Pharmacia & Upjohn Diag Ab Non-anaphylactic forms of grass pollen allergen and their use
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
GB0214942D0 (en) * 2002-06-28 2002-08-07 Secr Defence Immunogenic proteins and DNA encoding these
RU2372074C2 (ru) * 2002-11-26 2009-11-10 Альк-Абелло А/С Лекарственная форма, содержащая аллерген
ATE307141T1 (de) 2003-01-21 2005-11-15 Biomay Prod & Handel Verfahren zur vorbereitung von hypoallergenen mosaikproteine
RU2265450C2 (ru) * 2003-08-28 2005-12-10 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Способ получения клещевого аллергена для постановки диагностической пробы
US20060150283A1 (en) * 2004-02-13 2006-07-06 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060048240A1 (en) * 2004-04-01 2006-03-02 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
ES2340767T5 (es) * 2004-07-01 2013-11-13 Biomay Ag Alérgenos de ácaros del polvo doméstico
RU2630652C2 (ru) * 2011-06-09 2017-09-11 Биомей Аг Гибридные белки-носители пептидов в качестве вакцин от аллергии

Also Published As

Publication number Publication date
JP6105520B2 (ja) 2017-03-29
EP2027149B2 (de) 2013-08-28
AU2007246150A1 (en) 2007-11-08
EP2027149B1 (de) 2009-12-30
US20170218034A1 (en) 2017-08-03
US9963489B2 (en) 2018-05-08
ES2339173T3 (es) 2010-05-17
AT503530A1 (de) 2007-11-15
CN101432299A (zh) 2009-05-13
ES2339173T5 (es) 2013-12-12
EP2027149A1 (de) 2009-02-25
US20150104458A1 (en) 2015-04-16
CN101432299B (zh) 2013-05-29
WO2007124524A1 (en) 2007-11-08
RU2570563C2 (ru) 2015-12-10
CA2646158A1 (en) 2007-11-08
CA2646158C (en) 2016-04-19
AU2007246150B2 (en) 2012-06-07
US20090104208A1 (en) 2009-04-23
ATE453664T1 (de) 2010-01-15
JP2014221050A (ja) 2014-11-27
JP2009535020A (ja) 2009-10-01
RU2008146920A (ru) 2010-06-10

Similar Documents

Publication Publication Date Title
DE602007004110D1 (de) Hausstaubmilbenallergen
WO2007148224A8 (en) Polypeptide
NO20075927L (no) IL-21 varianter
ES2421719T3 (es) Antígeno de gliadina recombinante desamidada
NZ595303A (en) Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
NZ597692A (en) Anti-IGF antibodies
NZ595500A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
EA201170879A1 (ru) Полипептиды с ксиланазной активностью
EA201000327A1 (ru) Белок
DK2135949T3 (da) MCP-1-bindende nukleinsyrer
DE602005008996D1 (de) Radiofluorierte peptide
WO2009069808A1 (ja) 新規活性を有するEphA4ポリペプチドおよびその用途
BR112012006579A2 (pt) agonistas de npr-b.
NO20082989L (no) Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet
CY1111630T1 (el) Παραγωγα κυτοκινων
MX2007000334A (es) Polipeptido.
WO2008105178A1 (ja) リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
WO2006135793A3 (en) Protein engineering with analogous contact environments
EP2098594A4 (de) Nukleinsäuremolekül mit fähigkeit zur bindung an aus kaninchen stammenden igg-antikörper
WO2009105780A3 (en) Mntf peptide compositions and methods of use
WO2008109433A3 (en) Anti-angiogenic peptides
JP2009524413A5 (de)
WO2006123157A3 (en) Nematistatic protein
ATE544864T1 (de) Chemisch-enzymatische peptidsynthese mittels c- terminaler ester-umwandlung
WO2007147630A3 (en) Peptides regulating the surface expression of the t cell receptor

Legal Events

Date Code Title Description
8363 Opposition against the patent